Latest news and updates on the global coronavirus pandemic. Keep up-to-date on numbers of COVID-19 cases and deaths, analysis of the government's response, how the NHS is coping and other stories from the UK and around the world.

Cases overviewCasesDeaths
United Kingdom4,411,068127,577
Updated: Apr 22 9.24pm BST Data source: CDC, WHO

One dose of Pfizer or Oxford jab reduces Covid infection rate by 65% – study

  • One dose of Pfizer or Oxford jab reduces Covid infection rate by 65% – studyAnalysis of test results from more than 350,000 people finds older people just as protected as youngerCoronavirus – latest updatesSee all our coronavirus coverage A pharmacist prepares to administer the Oxford/ AstraZeneca vaccine. Because the vaccine was rolled out later than the Pfizer jab, it is too early to assess the impact of second doses. Photograph: Chris Jackson/Getty Images

have your say

Watch: Yahoo Explains

How do people feel about the AstraZeneca vaccine?

Under-30s in the UK will be offered Pfizer or Moderna vaccines rather than the Oxford/AstraZeneca vaccine due to concerns over a very rare risk of blood clots. The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK said there were still huge benefits of the vaccine in preventing Covid-19, and has not concluded that the vaccine causes rare clots, although it says the link is getting firmer.
  • 01:04
  • 02:52
  • 00:41
  • 02:26
  • 01:40
  • 02:59
  • 02:24
  • 01:54
  • 02:25
  • 02:11

Latest coronavirus news

  • The Independent

    Iowa prison staff gave 77 inmates overdoses of Pfizer’s Covid-19 vaccine

    No prisoners required outside medical treatment and they will be monitored for 48 hours

  • Evening Standard

    55 new cases of Indian ‘double mutant’ Covid-19 variant found in the UK

    It takes the total number of B.1.617 infections to 132, according to the latest figures released by Public Health England. Of these cases, 119 were found in England, five in Scotland and eight in Wales. It comes before India will be added to the UK’s travel “red list” on Friday.

  • Sky News

    COVID-19: Wales speeds up lifting of lockdown restrictions once again

    Wales is again speeding up the lifting of COVID lockdown restrictions by bringing forward further reopenings by two weeks. The Welsh government will allow more relaxations on 3 May than it had initially planned. This includes the resumption of indoor supervised activities for children, indoor organised activities for up to 15 adults, such as exercise classes, and the reopening of community centres.

  • The Independent

    Coronavirus lockdown easing brought forward in Wales as infections fall

    Indoor exercise classes and swimming lessons will resume two weeks earlier than planned, says first minister

  • Evening Standard

    UK coronavirus LIVE: Covid no longer leading cause of death as vaccines working ‘better than expected’

    Coronavirus was not the leading cause of death in England and Wales in March for the first time since October, new figures show. Office for National Statistics (ONS) data shows Covid-19 was the third leading cause of death in both countries that month, accounting for 9.2% of all fatalities registered in England and 6.3% in Wales. The virus was the leading cause of death each month from November to February.

  • Sky News

    COVID-19: 'I'm hoping collaboration can continue across borders' says Novavax vaccine maker

    The British manufacturer of the next coronavirus vaccine likely to be approved for general use in the UK has called on international governments to cooperate to ensure the global rollout is not interrupted by disputes. The UK has ordered 60 million doses of the Novavax vaccine, which was developed in the US but will be produced in part by Fujifilm Diosynth Biotechnologies at its facility in Billingham on Teesside. Production has already begun pending approval by the medicines regulator, and Fujifilm Diosynth's chief executive Martin Meeson told Sky News he was confident they would be able deliver if supply chains are not interrupted.

  • Sky News

    COVID-19: 55 new cases of Indian 'double mutation' variant found in UK in latest week

    A further 55 cases of the coronavirus "double mutation" variant first detected in India have been discovered in the UK in the week to 21 April, Public Health England (PHE) has said. The news comes just hours before India is added to England's travel red list on Friday, meaning arrivals will have to quarantine in hotels from then on for 10 days of isolation. Scientists are particularly concerned about the Indian variant, as it contains two significant mutations of the spike protein, which could mean vaccines are less effective against it.

  • The Telegraph

    David Cameron repeatedly lobbied Bank of England for coronavirus cash

    David Cameron repeatedly lobbied the Bank of England to help grant Greensill Capital access to a state-backed coronavirus support scheme, newly released documents reveal. The former prime minister complained in one email about the “incredibly frustrating” situation as the company was rejected access to the financial support by the Treasury. The 24 pages of documents, released under Freedom of Information laws, included emails Mr Cameron sent in March and April 2020 as the Covid-19 pandemic escalated. The messages raise fresh questions about whether Mr Cameron, who left Number 10 four years earlier, was granted better access than others because of his political connections. Some are signed off “DC”, for David Cameron, and indicate he had a prior working relationship with at least one figure he was attempting to persuade. They also shed light on the full scale of Mr Cameron’s lobbying on behalf of Greensill, a company that he began working for as an adviser after leaving politics.

  • The Independent

    EU prepares to sue AstraZeneca over failure to deliver enough Covid-19 vaccines

    Commission confirmed legal action being considered but says no decision yet made

  • The Independent

    ‘People are just so Zoomed out’: How Covid-19 has impacted 2021 Oscar campaigns

    Opulent industry affairs are just some of the ways studios romance the press and Academy voters, who decide the Oscar winners each year. But that all came to a screeching halt this awards season, however, thanks to the still-ongoing Covid-19 pandemic, writes Rachel Brodsky